𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung

✍ Scribed by Hanne Slott Jensen; Heine Høi Hansen; Per Dombernowsky

Book ID
112286027
Publisher
Springer
Year
1980
Tongue
English
Weight
248 KB
Volume
4
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Small cell anaplastic carcinoma of the l
Small cell anaplastic carcinoma of the lung
✍ Brian A. Brigham 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 554 KB

Small cell anaplastic lung cancer is increasingly considered to be potentially curable. The opinion that this tumor is a rapidly proliferating one has not been substantiated by kinetic studies, and for this reason late relapse may occur in complete remitters. Differential rates of response/relapse i

Phase II study of tiazofurin (NSC 286193
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma
✍ Paul Y. Holoye; David T. Carr; Hari M. Dhingra; Bonnie S. Glisson; Jin S. Lee; W 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 115 KB

Fourteen evaluable patients with small cell bronchogenic carcinoma received tiazofurin, an inhibitor of inosine monophosphate dehydrogenase, that progressed after one combination chemotherapy. No objective remission was observed at the dosage of 800 mg/m2 for 5 consecutive days. Toxicity was moderat